Physically demanding occupations may increase autoimmune disease risk in men, particularly inflammatory joint conditions, highlighting the importance of workplace prevention, early screening, and risk assessment.

Post-bariatric surgery success depends on consistent long-term care. Multidisciplinary follow-up helps prevent complications, supports mental and metabolic health, and sustains weight-loss outcomes.

Daily movement patterns may predict long-term health outcomes in people with knee osteoarthritis. Regular moderate activity supports symptom management, lowers mortality risk, and informs personalized care.

This review examines 7-year CROWN trial data showing lorlatinib’s unprecedented durability in ALK-positive NSCLC, highlighting survival gains, CNS protection, resistance suppression, and toxicity management.

Advanced heart failure is when symptoms worsen despite optimal medical treatment, making daily activities difficult. In this stage, early referral to a specialty team is critical for patients who may benefit from advanced therapies like LVAD, transplant, or palliative inotropes to prolong survival.

Reviewing Neuralink’s first clinical implant, this briefing examines brain-computer interfaces, patient impact, healthcare readiness, reimbursement, ethics, rehabilitation, and future integration into care delivery models nationwide.

One-year data suggest Abbott’s Navitor TAVI system delivers strong valve performance, low complications, and improved future coronary access planning for severe aortic stenosis patients.

Safe infant sleep requires consistent education, practical support, and accessible sleep spaces, helping families follow evidence-based practices that reduce SIDS and sleep-related deaths.

ASCO 2026 data highlight rising early-onset cancers, prompting earlier screening, genomic testing, fertility-focused care, and heightened suspicion as diagnoses increasingly affect younger adults worldwide today.

A fundamental shift is underway in advanced oncology: the move from continuous, 'treat-to-progression' regimens to high-efficacy, finite-duration protocols. This evolution redefines long-term patient management and offers new potential for durable, treatment-free responses.